Carlsmed Stock Faces A Crucial Week After Friday’s Drop
Carlsmed shares closed Friday at $11.42, down 3.3% on the day and 24% below their July 2025 IPO price. The company reported Q1 revenue of $16.1 million, up 58% year over year, but net loss widened to $8.7 million. Shareholders are set to vote on directors and auditor at the June 3 annual meeting. Management will meet investors at three healthcare conferences in June.
